Tradestie Institutional Equity Comparison Engine

VIVS vs ASMB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ASMB Overall Edge

ASMB Captures Institutional Edge (4โ€“0 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Assembly Biosciences, Inc (ASMB) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, VIVS trades at N/M Forward P/E with -10117.0% operating margin (-51.4% YoY revenue) versus ASMB at N/M Forward P/E and -31.8% operating margin (-72.6% YoY). In options structure, VIVS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against ASMB sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ASMB
VIVS N/M vs ASMB N/M Fwd P/E
Growth & Margin Winner ASMB
Op Margin -10117.0% vs -31.8% ยท YoY -51.4% vs -72.6%
Momentum & Technical Winner ASMB
1Y -87.0% vs -37.3% ยท 52W Pos 5% vs 16%
Options & Structure Winner ASMB
BREAKDOWN (N/A IV) vs UNCLASSIFIED (100th %ile IV)
VIVS NASDAQ
VivoSim Labs, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.29
+142.92% 1D
Market Cap $2.4M
1M Return +64.69%
1Y Return -86.99%
Forward P/E N/M
Unified AI Score
36.8 / 100 SELL
Tech 5.0 Fund 38.0 Flow 50.0 Mom 50.0
ASMB NASDAQ
Assembly Biosciences, Inc
Pharmaceutical Preparations
$22.50
+0.49% 1D
Market Cap $464.6M
1M Return +9.97%
1Y Return -37.31%
Forward P/E N/M
Unified AI Score
31.0 / 100 SELL
Tech 3.0 Fund 37.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VIVS -86.99% ASMB -37.31% Spread: +49.68 pp (ASMB Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
VIVS TTM Op. Margin: -10117.0% ASMB TTM Op. Margin: -31.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VIVS vs ASMB. Trailing 12-month operating profitability (VIVS -10117.0% vs ASMB -31.8%) and valuation multiples (VIVS N/M vs ASMB N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VIVS (3) vs ASMB (6)
Institutional Metric VIVS ASMB Criterion Row Winner
Market Capitalization Scale $2.4M $464.6M Larger Scale ASMB
Trailing P/E Ratio Valuation N/M 30.2x Lower Multiple ASMB
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -51.4% -72.6% Higher Growth VIVS
Operating Margin (TTM) Profitability -10117.0% -31.8% Higher Margin ASMB
Net Profit Margin Profitability 0.0% -16.6% Higher Margin VIVS
Return on Equity (ROE) Capital Efficiency -343.1% -4.6% Higher ROE ASMB
52-Week Range Position Momentum 5% ($0โ€“$3) 16% ($19โ€“$40) Stronger Trend ASMB
Beta / 30D Volatility Risk Regime 0.83ฮฒ ยท 480% Vol 0.99ฮฒ ยท 57% Vol Lower Realized Risk ASMB
Unified Institutional Score Composite Signal 36.8 / 100 (SELL) 31.0 / 100 (SELL) Higher Composite VIVS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VIVS vs ASMB Buy Guide
VIVS BREAKDOWN
73d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VIVS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ASMB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live ASMB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VIVS nor ASMB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.